CLOV (Clover Health Investments, Corp)
Insider Trading Activity
Every open-market purchase and sale reported by CLOV officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-17 | JOSEPH CLAY THORNTON | Interim CFO | Sell | — | — |
| 2026-08-13 | JOSEPH CLAY THORNTON | Interim CFO | A | — | — |
| 2026-08-13 | Karen Soares | Chief Legal Officer | A | — | — |
| 2026-08-10 | Andrew Toy | Chief Executive Officer | Sell | — | — |
| 2026-07-20 | Karen Soares | Chief Legal Officer | Sell | — | — |
| 2026-07-17 | Jamie L. Reynoso | CEO, Medicare Advantage | Sell | — | — |
| 2026-07-16 | Conrad Wai | CEO, Counterpart Health | Sell | — | — |
| 2026-07-16 | Karen Soares | Chief Legal Officer | Sell | — | — |
| 2026-07-16 | Andrew Toy | Chief Executive Officer | Sell | — | — |
| 2026-07-16 | Jamie L. Reynoso | CEO, Medicare Advantage | Sell | — | — |
| 2026-07-16 | JOSEPH CLAY THORNTON | Interim CFO | Sell | — | — |
| 2026-07-09 | Jamie L. Reynoso | CEO, Medicare Advantage | Sell | — | — |
| 2026-07-06 | Jamie L. Reynoso | CEO, Medicare Advantage | Sell | — | — |
| 2026-07-01 | Andrew Toy | Chief Executive Officer | Sell | — | — |
| 2026-06-18 | Jamie L. Reynoso | CEO, Medicare Advantage | Sell | — | — |
| 2026-06-17 | JOSEPH FRANK OLDAKOWSKI | VP OF FINANCE AND CONTROLLER | Sell | — | — |
| 2026-06-16 | Karen Soares | Chief Legal Officer | Sell | — | — |
| 2026-06-16 | Jamie L. Reynoso | CEO, Medicare Advantage | Sell | — | — |
| 2026-06-11 | Jamie L. Reynoso | CEO, Medicare Advantage | Sell | — | — |
| 2026-05-28 | Conrad Wai | CEO, Counterpart Health | Sell | — | — |
| 2026-05-19 | Carladenise Armbrister Edwards | Director | Sell | — | — |
| 2026-05-18 | JOSEPH CLAY THORNTON | Interim CFO | F | — | — |
| 2026-05-13 | Brady Patrick Priest | CEO of Clover Care Services | Sell | — | — |
| 2026-05-12 | Andrew Toy | Chief Executive Officer | F | — | — |
| 2026-04-21 | Brady Patrick Priest | CEO of Clover Care Services | F | — | — |
| 2026-04-16 | Jamie L. Reynoso | CEO, Medicare Advantage | F | — | — |
| 2026-04-16 | Karen Soares | Chief Legal Officer | F | — | — |
| 2026-04-16 | Conrad Wai | CEO, Counterpart Health | F | — | — |
| 2026-04-16 | JOSEPH CLAY THORNTON | Interim CFO | F | — | — |
| 2026-04-16 | Andrew Toy | Chief Executive Officer | F | — | — |
| 2026-04-16 | Brady Patrick Priest | CEO of Clover Care Services | F | — | — |
| 2026-04-07 | Jamie L. Reynoso | CEO, Medicare Advantage | F | — | — |
| 2026-04-03 | Karen Soares | Chief Legal Officer | A | — | — |
| 2026-04-03 | Andrew Toy | Chief Executive Officer | MIXED | — | — |
| 2026-04-03 | Conrad Wai | CEO, Counterpart Health | A | — | — |
| 2026-04-03 | Jamie L. Reynoso | CEO, Medicare Advantage | A | — | — |
| 2026-04-03 | Brady Patrick Priest | CEO of Clover Care Services | A | — | — |
| 2026-03-18 | Jamie L. Reynoso | CEO, Medicare Advantage | Sell | — | — |
| 2026-03-17 | Jamie L. Reynoso | CEO, Medicare Advantage | F | — | — |
| 2026-03-17 | Conrad Wai | CEO, Counterpart Health | F | — | — |
| 2026-03-17 | Karen Soares | General Counsel & Secretary | F | — | — |
| 2026-03-05 | Brady Patrick Priest | CEO of Home Care | Sell | — | — |
| 2026-02-18 | Karen Soares | General Counsel & Secretary | F | — | — |
| 2026-02-10 | Andrew Toy | Chief Executive Officer | F | — | — |
| 2026-02-02 | Peter J. Kuipers | Chief Financial Officer | F | — | — |
| 2026-01-20 | Karen Soares | General Counsel & Secretary | F | — | — |
| 2026-01-20 | Conrad Wai | CEO, Counterpart Health | F | — | — |
| 2026-01-20 | Andrew Toy | Chief Executive Officer | F | — | — |
| 2026-01-20 | Brady Patrick Priest | CEO of Home Care | F | — | — |
| 2026-01-20 | Jamie L. Reynoso | CEO, Medicare Advantage | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 29,158,480 | — |
| — | Chief Executive Officer | 9,459,316 | — |
| — | Chief Financial Officer | 5,758,353 | — |
| — | Chief Financial Officer | 4,857,303 | — |
| — | Director | 3,512,196 | — |
| — | Chief Technology Officer | 3,093,225 | — |
| — | CEO, Medicare Advantage | 2,814,640 | — |
| — | General Counsel | 2,718,857 | — |
| — | CEO, Counterpart Health | 2,535,755 | — |
| — | CEO of Value Based Care | 2,100,665 | — |
| — | CEO of Clover Care Services | 2,040,222 | — |
| — | Chief Legal Officer | 1,614,217 | — |
| — | Interim CFO | 1,249,526 | — |
| — | Chief Growth Officer | 872,821 | — |
| — | Director | 605,980 | — |
| — | Director | 602,814 | — |
| — | Director | 598,622 | — |
| — | Director | 597,987 | — |
| — | Director | 557,066 | — |
| — | VP OF FINANCE AND CONTROLLER | 299,067 | — |
| — | Director | 285,432 | — |
| — | Director | 180,029 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CLOV quote page; the site-wide leaderboard is on the insider transactions hub.